In this regard, as a master regulator of cell proliferation, mTOR has attracted considerable attention as a possible therapeutic target in oncology [15], and tumor-associated macrophages represent one of the most promising cellular targets [215], because PI3K/Akt/mTOR signaling mostly promotes their pro-tumor M2 polarization [216]. The gene discussed is AKT1; the disease is neoplasm.